Designs and manufactures scientific and technology products for use in applications, including life sciences, healthcare, astronomy, consumer manufacturing and art conservation from 2.75% to 3.25%. 2019 trading so far is in-line, expecting to meet expectations
27-Jul-2018 – 40.5p – £36.3m – PER 17.8
Final Results For The 12 Months To End March 2018 – Revenue up 35% to £14.5m (2017: £10.7m) with Adjusted PBT up 70%+ by £991,000 to £2,300,000 (2017: £1,309,000).
I have not looked at this before but it has recently appeared on my Standard Tech Screen. I like the look of this update and may well look to take an opening position here. If not it will go on my Watchlist.
25-Sep-2018 – 41.25p – £37.0m – PER 17.1
AGM Trading Update – A good start is about as much as I can glean from this.
I remain Neutral as based on growth forecasts it seems at best fairly priced (to me).
18-Dec-2018 – 34.5p – £30.9m – PER 13.3
Interim Results For The 6 Months To End October 2018 – Record breaking – Revenue up 23%, Adjusted PBT up 32%, outlook for the current year remains comfortably in-line with market expectations.
I considered this fairly priced last time I looked (41p) but this looks quite encouraging. I will keep an eye out for updates (upgrades) here and re-evaluate that 41p fair price.
Standard Tech Screen Qualifier
Latest Commentary – 27-Jul-2018 – 40.5p – £36.3m – PER 17.8
Latest results show that Revenue Growth and EPS Growth for 2018A were both about 40% or so. Annual Revenue growth for 2019E and 2020E is forecast as 5% or so and Annual EPS Growth for both years is forecast as <5%. With a PER of 17 or so it just seems too expensive here at this price.